Has Medical Properties Trust Bottomed Out? The Case for a Comeback
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on hospitals and other medical facilities. The company has been through an extremely trying couple of years, resulting in both dividend cuts and deteriorating share prices.
Now, however, things seem to finally be improving at Medical Properties Trust. Is MPW a buy as the business turns itself around, » Read more about: Has Medical Properties Trust Bottomed Out? The Case for a Comeback »
Read More
The Max Pain Trade Is…
If one market analyst is to be believed, the path of the market that will lead to most pain will involve a move higher from the early August lows followed by a sharp correction in September and October, repeating a pattern not seen since 1998.
Back then July marked the high and October the low,
» Read more about: The Max Pain Trade Is… »
Read More
Has The AI Bubble Officially Burst?
You’ll never guess who has turned bearish on AI? It seems one of the most prestigious names on Wall Street, Goldman Sachs, has done a U-turn and is betting against a continuation of the momentum previously seen in artificial intelligence stocks.
While Goldman has a long history of staying bullish, often for too long,
» Read more about: Has The AI Bubble Officially Burst? »
Read More
1 Billion Reasons To Buy Buffett’s #1 Stock
While Buffett’s massive cash pile of nearly $300 billion on the books at Berkshire Hathaway has been making waves, what few are paying attention to is how much he’s actually earning on that money every day, week or month.
It turns out Buffett is raking in just shy of a cool billion dollars each and every month just from interest earnings on his war chest.
» Read more about: 1 Billion Reasons To Buy Buffett’s #1 Stock »
Read More
This AI-Powered Sports Stock That Just Scored Big, Is It a Buy?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock to watch after soaring post earnings despite announcing mixed results for earnings versus revenue for Q4 of 2024.
The company surpassed consensus EPS estimates just once in the past four quarters but revenues have steadily increased and eclipsed consensus expectations.
» Read more about: This AI-Powered Sports Stock That Just Scored Big, Is It a Buy? »
Read MoreThe Burst
1 Under-the-Radar Pharma Stock with 90% Upside?
Billionaire Stanley Druckenmiller has been making large changes to his portfolio recently, leaving retail investors struggling to keep up with what the famous stock picker is thinking.
One of the smaller holdings in Druckenmiller’s portfolio that makes for interesting examination is ARS Pharmaceuticals (NASDAQ:SPRY).
Druckenmiller’s 536,900 shares of SPRY are currently valued at around $7 million.
» Read more about: 1 Under-the-Radar Pharma Stock with 90% Upside? »
Read MoreThe Spotlight
1 Stock Buffett Likes More Than Apple
Stocks have pulled back in the past month, as interest rates and inflation continue to dog the market. The AI excitement that gripped investors earlier in the year has abated somewhat, leading to recent pullbacks in stocks like Nvidia and Microsoft.
Apple has struggled to make an impact with investors because the company has lagged behind its competitors in launching AI-powered products.
» Read more about: 1 Stock Buffett Likes More Than Apple »
Read MoreThe Daily
USD sees worst start in 50 years thanks in part to Trump's tariffs — but for investors it's not all bad news
We adhere to strict standards of editorial integrity to help you make decisions with confidence.